Form 4: Interparfums Director Exercises Options, Sells Shares
Insider Transaction Report
Interparfums Director Gilbert Harrison reported exercising stock options and subsequently selling a portion of his common stock holdings.
Summary
- Director Gilbert Harrison acquired 1,500 shares of Interparfums Inc. common stock on January 22, 2026, through the exercise of stock options at a price of $62.18 per share.
- On the same date, Harrison disposed of 1,550 shares of common stock.
- Following these transactions, Harrison beneficially owns 3,050 shares of Interparfums Inc. common stock directly.
- The exercised options were part of grants with an exercise price of $62.18 and an expiration date of January 31, 2026.
- Harrison continues to hold various tranches of unexercised stock options with exercise prices ranging from $84.64 to $147.71 and expiration dates extending to December 30, 2031.
Sentiment
Score: 5
Explanation: The transaction is a routine insider exercise and sale, which is neutral. The net sale of 50 shares is minor and does not indicate strong negative sentiment or a significant change in the director's overall holdings.
Positives
- Director Harrison exercised options, indicating a realization of value from previously granted equity compensation.
- The exercise price of $62.18 for the options exercised is significantly lower than the implied market price at which the shares were disposed, suggesting a profitable transaction for the insider.
Negatives
- Director Harrison disposed of 1,550 shares of common stock, resulting in a net reduction of 50 shares in his direct common stock holdings (1,550 disposed 1,500 acquired).
Risks
- Insider sales, even when part of routine compensation or financial planning, can sometimes be perceived negatively by the market if not clearly understood or if they are substantial, potentially leading to minor short-term price fluctuations.
Future Outlook
NA
Industry Context
This Form 4 filing details an individual insider transaction and does not provide broader industry context or trends.
Related Party Transactions
- Director Gilbert Harrison's transactions involving Interparfums Inc. securities are considered related party transactions as he is a director of the company.
Stakeholder Impact
- Shareholders: A minor net reduction in direct common stock holdings by a director could be perceived as slightly negative, but the overall impact is likely minimal given the small number of shares relative to the company's total outstanding shares.
- Employees: No direct impact.
- Customers: No direct impact.
- Suppliers: No direct impact.
- Creditors: No direct impact.
Key Dates
| Date | Description |
|---|---|
| 02/01/2022 | Date exercisable for a tranche of 375 options with an exercise price of $62.18, expiring 01/31/2026. |
| 02/01/2023 | Date exercisable for a tranche of 375 options with an exercise price of $62.18, expiring 01/31/2026. |
| 12/31/2023 | Date exercisable for a tranche of 300 options with an exercise price of $97.84, expiring 12/30/2028. |
| 02/01/2024 | Date exercisable for a tranche of 375 options with an exercise price of $62.18, expiring 01/31/2026. |
| 12/29/2024 | Date exercisable for a tranche of 300 options with an exercise price of $147.71, expiring 12/28/2029. |
| 12/31/2024 | Date exercisable for a tranche of 300 options with an exercise price of $97.84, expiring 12/30/2028. |
| 02/01/2025 | Date exercisable for a tranche of 375 options with an exercise price of $62.18, expiring 01/31/2026. |
| 12/29/2025 | Date exercisable for a tranche of 300 options with an exercise price of $147.71, expiring 12/28/2029. |
| 12/31/2025 | Date exercisable for tranches of 300 options with exercise prices of $97.84 (expiring 12/30/2028) and $130.6 (expiring 12/30/2030). |
| 01/22/2026 | Date of earliest transaction, involving the exercise of 1,500 options and disposition of 1,550 common shares. |
| 01/23/2026 | Signature date of the reporting person, Gilbert Harrison. |
| 01/31/2026 | Expiration date for four tranches of options with an exercise price of $62.18. |
| 12/29/2026 | Date exercisable for a tranche of 300 options with an exercise price of $147.71, expiring 12/28/2029. |
| 12/31/2026 | Date exercisable for tranches of 300 options with exercise prices of $97.84 (expiring 12/30/2028), $130.6 (expiring 12/30/2030), and $84.64 (expiring 12/30/2031). |
| 12/29/2027 | Date exercisable for a tranche of 300 options with an exercise price of $147.71, expiring 12/28/2029. |
| 12/31/2027 | Date exercisable for tranches of 300 options with exercise prices of $97.84 (expiring 12/30/2028), $130.6 (expiring 12/30/2030), and $84.64 (expiring 12/30/2031). |
| 12/29/2028 | Date exercisable for a tranche of 300 options with an exercise price of $147.71, expiring 12/28/2029. |
| 12/30/2028 | Expiration date for five tranches of options with an exercise price of $97.84. |
| 12/31/2028 | Date exercisable for tranches of 300 options with exercise prices of $97.84 (expiring 12/30/2028), $130.6 (expiring 12/30/2030), and $84.64 (expiring 12/30/2031). |
| 12/28/2029 | Expiration date for five tranches of options with an exercise price of $147.71. |
| 12/31/2029 | Date exercisable for tranches of 300 options with exercise prices of $130.6 (expiring 12/30/2030) and $84.64 (expiring 12/30/2031). |
| 12/30/2030 | Expiration date for five tranches of options with an exercise price of $130.6. |
| 12/31/2030 | Date exercisable for a tranche of 300 options with an exercise price of $84.64, expiring 12/30/2031. |
| 12/30/2031 | Expiration date for five tranches of options with an exercise price of $84.64. |
Recommendation
holdThe reported insider transaction is routine, involving the exercise of options and a subsequent sale of a small number of shares. It does not indicate a significant change in the company's fundamentals or the director's long-term view, thus a 'hold' recommendation is appropriate based solely on this filing.
Keywords
Interparfums, IPAR, SEC Form 4, Insider Trading, Stock Options, Director Transaction, Equity Compensation, Share Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.